Maryland Cannabis News

Trump Dismisses GOP Lawmakers’ Opposition To His Marijuana Rescheduling Action, Pointing To Polling And Medical Benefits

The Maryland Cannabis Administration fined Green Leaf Medical, LLC, d/b/a The Cannabist Company $33,000 for cannabis sampling and recordkeeping violations, including improper METRC tracking and providing samples to non-registered attendees, resulting in a consent order that mandates staff training, updated procedures, and a one-year ban on sampling events.

GOP Lawmakers Urge Trump Not To Reschedule Marijuana In Last-Ditch Effort To Block Historic Reform

White House Confirms Trump Will ‘Address Marijuana Rescheduling’ Thursday, But Reported Details On Final Decision Are ‘Speculation’

Most Americans Back Legalizing Marijuana, But Trump Voters Not On Board, Conservative Group’s Poll Shows Amid Rescheduling Rumors

Trump’s Marijuana Rescheduling Order Could Include Industry Banking And CBD Medicare Coverage Provisions, Sources Say

GOP Congressman Says Trump ‘Technically’ Can’t Reschedule Marijuana On His Own, But Reversing It In Congress Would Be A ‘Heavy Lift’

Key developments include the Senate debating financial access issues for cannabis businesses and the House approving a bill targeting online marijuana ads. Sen. Rand Paul is working to reverse federal recriminalization of hemp THC products, while prohibitionist groups asked the Supreme Court to uphold the ban on gun possession for cannabis users. Additionally, studies showed positive findings on CBD's use among athletes and its therapeutic potential for various health conditions, and Michigan reported high monthly marijuana sales.

Senator Rand Paul (R-KY) previewed legislation to counter a forthcoming federal ban on consumable hemp products, which he warns could devastate the $25 billion industry; his proposed bill would allow state-level regulation with basic safeguards to supersede the new federal restrictions.

- The NZMCC Industry Day focused on connection and collaboration among patients, clinicians, cultivators, and policymakers in the medicinal cannabis sector.
- The program featured a Leaders’ Roundtable and regulatory briefings, followed by specialized afternoon pathways addressing clinical practice (terpene tailoring, prescribing challenges) and industry topics (cultivation innovation, export readiness, and sustainability).
- NZMCC plans to establish working groups in 2026 focused on priority areas including export markets and patient access.

Only Six Percent Of Marijuana Consumers Approve Of Trump’s Reform Actions, But Most Would Shift Opinion If He Reschedules, Poll Finds

YANA Wellness, a women-owned and operated cannabis brand led by CEO Ariana Fleishman, made history as the first hemp-derived THC beverage line sold in all Total Wine retail locations across Virginia. Fleishman established the brand to advocate for plant-based wellness alternatives over normalized alcohol and prescription drugs, developing a variety of compliant blends to navigate federal prohibition and expand nationwide access. YANA emphasizes social responsibility, research (collaborating with universities on the psychological effects of cannabis and mushrooms), and stimulating the local economy through strategic partnerships with family-owned Virginia businesses for manufacturing and distribution.

A major drug testing organization, the National Drug & Alcohol Screening Association (NDASA), is opposing the rumored proposal to reschedule marijuana from Schedule I to Schedule III, warning that without a "Safety Carve Out," it would create dangerous loopholes allowing transportation employees like pilots and truck drivers to use cannabis without mandatory testing. Proponents, including cannabis industry stakeholders, are hopeful for the reform, which would recognize marijuana's medical value and represent a significant change in federal policy, though a final decision has not yet been announced by the White House.

Democratic Senators Wyden and Merkley introduced the Cannabinoid Safety and Regulation Act to establish a federal regulatory framework for hemp-derived cannabinoids, creating an alternative to the impending broad ban set to take effect next November. The bill would empower the FDA to set safety standards, require businesses selling consumable products to register, enforce federal labeling rules, and limit total THC content in products (e.g., 5 milligrams per serving and 50 milligrams per package for most items).

A pending federal ban on most consumable hemp products, set for November implementation, has prompted a Congressional Research Service report suggesting that enforcement may be guided by existing federal non-enforcement policies toward state marijuana laws. The new legislation drastically redefines legal hemp by limiting "total THC" and banning most synthesized cannabinoids, causing widespread industry outcry and spurring lawmakers to seek an alternative regulatory model or outright repeal before the prohibition takes effect.

Congressional researchers warn it remains unclear how the FDA and DEA will enforce the newly enacted federal law banning certain hemp THC products next year, citing a potential lack of agency resources. The legislation alters the definition of legal hemp by applying weight limits to total THC (including isomers like delta-8) and banning synthetic cannabinoids, prompting stakeholders and lawmakers to seek an alternative regulatory framework before the prohibition takes effect.

Bipartisan lawmakers introduced the "Freedom to Heal Act" to allow doctors to administer Schedule I psychedelics, such as MDMA and psilocybin, to patients with life-threatening or severe mental health conditions under the country’s "right to try" law. The legislation would amend the Controlled Substances Act to create a pathway for the DEA to authorize physicians to use these FDA-designated breakthrough therapies for patients who have exhausted approved treatments.

A GOP congressman questioned federal financial regulators about the difficulties state-legal marijuana businesses face in accessing banking services due to federal prohibition. Many banks resist accepting cannabis businesses as clients because marijuana remains a Schedule I drug under the Controlled Substances Act. Although the House has passed versions of the SAFER Banking Act seven times, key lawmakers believe its prospects are currently doubtful, as it has taken a back seat to other legislative priorities, though rescheduling cannabis might help advance the measure.

DOJ cannabis enforcement guidance revealed

A government-funded study found that state agencies regulating marijuana largely outperform alcohol regulatory agencies concerning public health goals, activities, and policies. The analysis showed 68 percent of cannabis regulators referenced public health goals in their mission statements, compared to only 35 percent of alcohol regulators, suggesting marijuana is currently regulated more robustly than alcohol regarding key public health measures.

Minnesota officials, including Governor Tim Walz and members of Congress, are actively seeking ways to counteract an impending federal ban on hemp-derived THC products set for next November, fearing it will disrupt the state's thriving industry. Lawmakers are pushing for an alternative regulatory framework, similar to Minnesota's current state-level rules, to replace the prohibition and prevent the re-criminalization of consumable hemp products.

A federal lawsuit challenges D.C.’s cannabis enforcement, which continues with the shutdown of Snackz DC and raids on Virginia vape shops; meanwhile, Maryland dispensaries reported record sales, and a task force recommended decriminalizing psychedelics. ABCA also announced upcoming board meetings, leadership updates, and an HR manager opening.

GOP Congressional Leader Is ‘Cautiously Optimistic’ Trump Will Reschedule Marijuana—Which He Says Is ‘An Alternative To Highly Addictive Opioids’

A proposed policy change slipped into a budget deal aims to eradicate the legal hemp industry, which would wipe out a $28+ billion market and 300,000 jobs while driving production to the black market. The author argues that Congress should choose regulation—with testing, potency limits, and age gating—over prohibition to address public safety concerns properly.

Minnesota congressional Democrats are urging Congress to quickly fix a recently enacted federal spending bill provision that bans most consumable THC products, which they warn will devastate the state's growing and regulated hemp industry. They are advocating for a new federal regulatory framework, modeled after Minnesota's successful state rules that include age restrictions and safety standards, and are seeking bipartisan support to reverse the ban before it takes effect next year.

GOP members of the Senate Appropriations Committee released a spending bill and a report reminding D.C. that marijuana remains federally illegal, emphasizing enhanced penalties for sales near schools. The legislation continues to include a rider that bans D.C. from using local funds to create a regulated recreational cannabis market, despite voters approving possession and cultivation years ago.

The summary covers several topics in cannabis and drug policy: a judge grilling a DEA lawyer over a psychedelic petition delay; lawmakers, including Rep. Ilhan Omar, preparing to push for an exemption to the hemp-derived THC ban for regulated states; Joe Rogan criticizing the recriminalization of hemp products and blaming the alcohol lobby; a study finding cannabis reduces alcohol consumption; Texas advancing hemp age restriction rules; and updates on federal, state, local, and international cannabis policy developments, as well as new science and business reports.

Congressional Lawmakers Want Exemption From Federal Hemp THC Ban For States With Regulations

New federal THC limits threaten small hemp operations and thousands of jobs in Maryland. In Virginia, AYR Wellness' foreclosure could delay medical cannabis permits ahead of a planned adult-use market launch in fall 2026. West Virginia’s medical cannabis program is experiencing slow growth and high prices, leading patients to look for more affordable options out of state.

West Virginia's medical cannabis patients are struggling with high prices and limited product access, leading many to illegally cross state lines to purchase cheaper recreational cannabis and edibles in neighboring states like Ohio and Maryland. The state's medical cannabis program has high overhead costs due to factors like no outdoor growing, a 10% sales tax on dispensaries, and lack of insurance coverage or tax exemptions due to federal illegality. Patients and advocates are pushing for an expansion of the program, potentially to a recreational market, to lower costs and broaden access, but state officials have not implemented price caps or changed the Medical Cannabis Act since 2021.

Trump admin declines to file cannabis brief at SCOTUS (Newsletter: November 19, 2025)

Verilife is offering a special discount on top products for Green Wednesday, and customers visiting any Maryland Verilife location during the week of 11/23 can redeem a doorbuster with a single in-store purchase.

GOP Lawmakers ‘Forced’ Trump Into Signing Hemp Ban, Longtime Ally Roger Stone Says

GOP Operative Roger Stone Blasts ‘Cheap Cop-Out’ Hemp Ban That Trump Signed Into Law

Kentucky Governor Says Hemp Is An ‘Important Industry’ That Should Be Regulated At The State Level, Not Federally Banned

The Veterans of Foreign Wars (VFW) is warning Congress that a new blanket ban on consumable hemp products, included in a recently signed spending bill, could jeopardize critical scientific research into hemp-derived cannabinoids. The VFW argues these products offer a safer alternative to heavy prescription drugs for veterans dealing with PTSD, anxiety, pain, and sleep problems. They urge a balanced approach that protects consumers but allows research to continue, stating that a ban would hurt small businesses and drive veterans to the black market. The new legislation changes the definition of legal hemp, applying weight restrictions to total THC (including delta-8 and other isomers) and banning certain intermediate and synthesized products. It also sets limits on total THC per container. Advocates are seeking a compromise before the prohibition is implemented next year. The spending bill also controversially omits bipartisan provisions that would allow VA doctors to recommend medical cannabis in states where it is legal.

Marijuana legalization was not included in Pennsylvania's final budget deal despite the governor's support. Several lawmakers believe there is a path forward for legalization in the 2026 session, seeing it as a necessary source of state revenue. While some Democratic lawmakers are disappointed by the Senate's lack of support, others are optimistic that legalization is a matter of "when" not "if." Separately, there is a bipartisan bill moving forward to create a Cannabis Control Board to oversee the medical program and prepare for adult-use. GOP opposition remains the primary hurdle, with one Republican candidate for governor expressing doubt about projected cannabis revenue.

Trump signs bill recriminalizing hemp THC products (Newsletter: November 13, 2025)

Trump Signs Bill To Recriminalize Hemp THC Products, Years After Approving Their Legalization

The House is preparing to vote on a Senate-passed spending bill that includes a ban on consumable hemp products. Attempts by Republican Representatives Paul Rand and Thomas Massie to strike the prohibition language failed. Republican Representative Morgan Griffith is voting for the underlying bill to avoid a government shutdown, despite disagreeing with the hemp ban. Democratic Senator Chris Van Hollen supported the ban due to concerns about unregulated synthetic hemp products being sold to children, but suggests Congress should use the one-year before implementation to develop a regulatory framework to preserve access to safe hemp products like CBD. Advocates are also criticizing the bill for omitting bipartisan provisions allowing VA doctors to recommend medical cannabis.

The Maryland Task Force on Responsible Use of Natural Psychedelic Substances delivered a 373-page report to lawmakers advising a multi-phase approach to legalization. The task force suggests first enacting reforms for psilocybin, including deprioritizing personal possession and cultivation, establishing an advisory board for therapeutic protocols, and including expungement policies. This would be followed by establishing clinical access and "full operation and expansion" of the industry, including commercial sales. The report suggests using this experience when considering reforms for other natural psychedelics. Currently, only Oregon and Colorado have therapeutic psilocybin programs, and the FDA gave psilocybin a breakthrough therapy designation in 2018 for research on treatment-resistant depression.

The newsletter covers several cannabis-related developments, including the deletion of provisions for VA medical marijuana recommendations, a Virginia senator's optimism about legalizing recreational cannabis sales, and Texas's new hemp law checklist. It also mentions Sen. Ted Cruz's support for keeping hemp THC products federally legal, struggles faced by Missouri marijuana microbusinesses, and various state-level regulatory updates. Finally, it includes brief sections on international news, science and health studies related to cannabis, advocacy, and business updates.

D.C. expanded medical cannabis reciprocity and finalized tamper-proof packaging rules. Maryland proposed social equity license extensions, and Virginia moved to digital medical certifications. Baltimore nonprofits are hosting a food and diaper drive in November.

Senate rejects amendment to protect hemp products’ legality (Newsletter: November 11, 2025)

Hemp business lawyers and industry stakeholders are opposing a "disastrous" congressional proposal to ban hemp products with THC, arguing it is overbroad and will harm responsible commerce and the industry. They disagree with attorneys general who claim state-level regulation is inadequate, pointing to effective state regulation of alcohol as a parallel. They urge Congress to allow states to continue regulating hemp products instead of including a ban in the appropriations bill, which they warn would devastate the industry, potentially even making nonintoxicating CBD products illegal. The text also notes division among alcohol stakeholders regarding the ban and highlights the differing positions of GOP senators like Mitch McConnell, who supports the ban, and Rand Paul, who opposes it and has introduced legislation to increase the legal THC concentration for hemp.

Maryland's proposed cannabis regulations include extending conditional license deadlines from 18 to 24 months, strengthening contamination controls, reducing fees, and increasing operational flexibility for dispensaries and micro-licensees.

The summary covers several cannabis and psychedelics policy updates, including conflicting industry stances on intoxicating hemp products (one group urging recriminalization, another urging regulation like alcohol), Nebraska AG's warning against buying marijuana, the Maryland task force's recommendation for phased psychedelics legalization starting with psilocybin, and FBI data showing marijuana arrests as a primary driver of drug war enforcement. Other updates include South Dakota's recommendation for tighter medical cannabis and hemp regulations, various state-level regulatory actions and new laws, and financial reports from several cannabis businesses.

Over 50 alcohol distributors are opposing efforts in Congress to ban intoxicating hemp products, arguing that the cannabis market helps sustain their industry as alcohol demand shifts downward. They urge lawmakers to regulate and tax these products like alcohol, drawing parallels to the failure of alcohol prohibition. The article notes division among alcohol stakeholders, with some major industry associations and consumer trade groups actually supporting a ban, at least temporarily. Additionally, 39 state and territory attorneys general are calling for clearer federal definitions and regulations for cannabinoid products. The issue remains contested in Congress, with lawmakers like Sen. Mitch McConnell pushing for a ban while Sen. Rand Paul opposes it and advocates for more lenient regulations.

The Maryland Task Force on Responsible Use of Natural Psychedelic Substances released a final report recommending a multi-phase framework for legal, therapeutic access to natural psychedelics, starting with psilocybin. The plan involves phased implementation of medical/therapeutic use, supervised adult use, deprioritization measures, and eventually commercial sales, with the goal of ensuring safe, broad, and equitable access. The task force does not support delaying state action pending future FDA approval and emphasizes an "ensemble model" approach that balances public health, patient safety, equity, and scientific integrity, positioning Maryland as a potential national leader in psychedelic policy reform. The report also estimates potential client numbers and consumer spending if psilocybin is legalized.

Steve Bevan, a key figure in drafting the hemp language in the 2018 Farm Bill, argues that the emergence of intoxicating cannabinoid products is not due to a "loophole" but rather the intentional language added to the law and subsequent inaction by lawmakers and regulators like the FDA. Bevan's letter to GOP leaders opposes a proposed ban, suggesting that simple age restrictions and regulation are the solution, not prohibition, which he claims would only boost the illicit market. He suggests that state attorneys general advocating for a ban are likely motivated by competition with the cannabis businesses in their states. The article also notes that major alcohol industry associations support a ban and highlights the disagreement among GOP lawmakers, with Senator Rand Paul opposing the ban aggressively, while Senator Mitch McConnell pushes for it. Congress has two options: prohibit the products or create a regulatory framework with quality standards and age requirements.

D.C.'s medical cannabis sales were $7.8 million in September, down 5% from August, but manufacturing, concentrate, and infused product sales showed strong growth, with out-of-District patients from Maryland, Virginia, and Florida as key buyers. Maryland provided a $217,000 grant for cannabis workforce training, police paused the "Green Lab" study due to high volunteer interest, and Virginia's unestablished retail cannabis market is becoming a focus ahead of the gubernatorial race, coinciding with a new online training program for healthcare professionals.

Major alcohol industry associations are urging Congress to temporarily ban intoxicating hemp products until a federal regulatory framework is established. They argue that the ambiguous language in the 2018 Farm Bill has led to an unregulated market for intoxicating cannabinoids like delta-8 and delta-9 THC. This push aligns with some lawmakers, like Sen. Mitch McConnell and Rep. Andy Harris, who support a ban, and 39 state attorneys general. However, other alcohol interests, such as Wine & Spirits Wholesalers of America (WSWA), oppose a full prohibition, and Sen. Rand Paul is strongly against a ban, arguing it would devastate the hemp industry and preferring regulatory reform, such as his proposed HEMP Act to triple the legal THC concentration.

The summary covers several cannabis-related developments: a lawyer is "hopeful" yet "nervous" about the Supreme Court taking up a federal prohibition lawsuit; the Minnesota AG defended signing a letter to recriminalize hemp THC products while seeking state carve-outs; Massachusetts is considering employment protections for marijuana users; Seth Rogen commented on the push to ban THC drinks; a Nebraska tribe claims punishment for its legalization plan; Sen. Mitch McConnell's office disputed claims he's ending his push for a hemp THC ban; Colorado's governor proposed transferring excess marijuana revenue to education; and Planet 13 Holdings is divesting a California retail store and closing a cultivation facility.

Employees at Nature's Care and Wellness, a medical cannabis dispensary in Cecil County, are accusing management of retaliation and intimidation after they started efforts to unionize with UFCW Local 27.

Minnesota Attorney General Keith Ellison is defending his decision to sign a bipartisan letter urging Congress to federally ban the sale of intoxicating hemp products, despite supporting Minnesota's regulated THC edible industry. Ellison argues the federal 2018 Farm Bill created an unintended "loophole" leading to unregulated, highly potent THC products entering the state and being marketed to children. His intent is to close this loophole and protect Minnesota's regulations. The AG's office clarified they support a federal "carve-out" for states with adequate regulatory schemes or an enforcement discretion memo. Industry stakeholders and some lawmakers, like Sen. Rand Paul (R-KY), oppose a total ban, arguing it would devastate the market. Other lawmakers, like Sen. Mitch McConnell (R-KY), are pushing for an outright ban.

The summary covers several cannabis and psychedelics policy updates, including Sen. Rand Paul's threat to block a government shutdown bill over a provision that would recriminalize hemp products with THC, Idaho activists launching a medical cannabis legalization initiative for 2026, a poll showing Canadians believe the cannabis industry is an important economic contributor, and Arizona approving a clinical trial for whole mushroom psilocybin to treat PTSD in veterans and first responders. It also mentions a study on marijuana aroma and terpenes, state-level policy news, international developments like Lebanon legalizing medical cannabis cultivation, and business/culture news.

In September, D.C.'s medical cannabis sales totaled $7.8 million, a 5% drop from August due to a seasonal slowdown, although manufacturing, concentrate, and infused product sales showed strong growth, with Maryland, Virginia, and Florida patients being top buyers. Regional developments included a $217,000 Maryland grant for cannabis workforce training, a temporary pause in a police-run cannabis impairment study due to high volunteer response, renewed focus on Virginia's unestablished retail market ahead of the gubernatorial race, and the launch of a new online training program for healthcare practitioners.

Multistate operator MariMed Inc. is exiting the Missouri market immediately following a strategic review of its business operations there. The company had been managing the Missouri operations of another licensed cannabis operator since 2024 under an agreement while awaiting license transfer approval, but will no longer manage the facility or seek the transfer. MariMed expects this exit to improve its financial performance and allow management to focus resources on higher-return opportunities, as it continues to own or manage 13 dispensaries and six cultivation and processing facilities across Delaware, Illinois, Maryland, Massachusetts, Ohio, and Pennsylvania.

A bipartisan coalition of 39 state and territory attorneys general is urging Congress to clarify the federal definition of hemp in the 2018 Farm Bill and impose regulations to prevent the sale of intoxicating cannabinoid products, arguing that the current interpretation has been exploited to sell synthetic THC products, often marketed to minors. They are asking for legislative changes to make these products illegal. Industry stakeholders, however, express concern that a ban could jeopardize the entire hemp market and suggest a middle-ground approach with age-gating and safety standards. Separately, Senator Rand Paul (R-KY) is advocating for a study into state regulatory models and has proposed legislation to triple the legal THC concentration for hemp, opposing efforts by Senator Mitch McConnell (R-KY) to champion criminalization language.

CULTA appointed Joseph Andreae as CEO. He brings experience from other cannabis programs and will focus on building an experienced leadership team, leveraging infrastructure for product quality, maintaining company culture, and differentiating the company through new values prioritizing staff and customers, cultivation integrity, and elevating the perception of cannabis.

A seasoned cannabis executive will help a Maryland company advance its commitment to craft, quality, and community.

The newsletter covers several cannabis and drug policy updates, including marijuana companies petitioning the U.S. Supreme Court to challenge federal prohibition, a hemp dispute in Congress, and state updates from Kentucky (15,000 registered medical cannabis patients) and Texas (expanding medical marijuana access). A new study indicates more Americans now use marijuana than smoke cigarettes. Other topics include state-level regulatory updates, a Texas DA lawsuit over refusing to enforce drug laws, a rejection of New York regulators' request on licensing residency privileges, and international news on German cannabis imports. The science section notes that cannabinoids offer modest, condition-specific pain relief and a study on psilocybin-assisted therapy for depression. Lastly, Canadian retailers sold C$498.7 million worth of legal marijuana products in August.

Maryland awarded a $217K EARN grant to CannaWorkforce to expand cannabis workforce training in 2026, which includes new laboratory technician programs and supports job placement for unemployed and underemployed Maryland residents.

The National Association of Attorneys General (NAAG), representing 39 state and territory attorneys general, sent a letter to Congress seeking clarification on the federal definition of hemp in the 2018 Farm Bill. The letter argues that the growing market for hemp-derived THC products is based on a misinterpretation of the law and asks Congress to clarify the definition of hemp to ensure these "harmful products are illegal."

West Virginia's medical cannabis program has collected approximately $34 million in taxes and fees since 2021, which state law requires be used for a medical cannabis research program, substance use disorder resources, and law enforcement training. However, the money remains unspent because cannabis is illegal at the federal level, and traditional banks refused to hold the funds. The money is currently held by a credit union, and the treasurer's office states it will remain unallocated until federal law changes. Other states with legal cannabis markets are spending their tax revenue. Lawmakers who drafted the original legislation expressed surprise that the funds are stockpiling. If the money were distributed today, it would be allocated to public health, substance abuse programs, and law enforcement training.

A Maryland cannabis company signed an agreement to expand its presence nationally.

D.C. dispensaries face oversupply, reducing sales. A court ruling set a precedent against nuisance marijuana smoking. Illegal operations like Tobacco King & Vape and Mother Earth Mushroom Church were shut down. Maryland police started the "Cannabis Green Lab" for impairment research. Virginia license applicants face tough competition and regulations.

The cannabis market in D.C. is growing rapidly, potentially too fast. With a high number of dispensaries compared to Maryland and Pennsylvania, sales per store are decreasing and prices remain elevated, indicating that more shops do not necessarily lead to a stronger market.

The newsletter provides updates on cannabis-related legislation and political developments across the US, including contrasting views from NJ governor candidates, advancing cannabis and hemp bills in OH and PA, and the approval of a timeline for dispensary licenses in RI. It also covers federal lobbying efforts by alcohol and other companies around hemp drinks, a pause in a judicial nomination amid a marijuana legalization campaign investigation, and research into CBD-like compounds developed from caraway seeds. International, scientific, business, and cultural cannabis news are also included.

The summary covers various cannabis-related developments, including: US senators discussing if rescheduling cannabis would aid banking legislation; a scheduled Pennsylvania Senate vote on a cannabis control board bill; a Massachusetts official expressing concern over proposed recriminalization initiatives impacting tax revenue; NYC mayoral candidates discussing cannabis use; an overwhelming volunteer turnout for a Maryland police DUI recognition training event involving smoking marijuana; a study suggesting legalization is associated with reduced opioid use among cancer patients; hearings on bills to reduce regulatory burden in Michigan and criticism of restrictive rules in Nebraska; federal updates on a Navy Admiral's retirement and a request to ban mention of legalization during a cultivation trial; state-level actions in New Mexico, New York, California, Delaware, Connecticut, U.S. Virgin Islands, Oklahoma, Massachusetts, and Nevada; a local fine reduction in La Crosse County, Wisconsin; science and health studies on pain reduction and post-legalization use prevalence; and business news including an acquisition and Colorado's July sales.

A summary of the Marijuana Moment newsletter includes new FBI data on marijuana arrests, a VA official's comments on psychedelics for veterans, Oklahoma's marijuana legalization initiative deadline, and the Marijuana Policy Project's call for industry and advocacy collaboration. Other topics include studies on cannabis as an opioid alternative, legal challenges to hemp product bans in Ohio, proposed cannabis rules in Missouri, and various state and international cannabis policy updates.

Nearly 188,000 people were arrested for marijuana possession and another 16,000 for selling or growing cannabis in the U.S. last year, according to the FBI's latest annual crime report. While these figures are likely understated due to data inconsistencies, cannabis-related offenses saw a slight decrease from 2023. Despite the reduction, marijuana remains the most common illegal substance for which Americans are arrested. The FBI's data has faced criticism for inconsistencies and incomplete reporting from state and local police, making it challenging to draw accurate policy conclusions. The Drug Enforcement Administration (DEA) also noted that the marijuana rescheduling process remains stalled.

In D.C., Chocolate City Wellness was suspended for 30 days due to illegal cannabis sales. In Maryland, three social equity licensees (Koan Cannabis, Elevated Dispo, and Elevated Releaf) received operational licenses. In Virginia, small cannabis businesses voiced concerns about regulatory fairness.

The latest quarterly tracking poll conducted by Marijuana Moment and NuggMD
shows that cannabis consumers are largely unimpressed with President Donald
Trump’s actions on the issue so far—and that most believe the CBD video the
president posted “does not mean anything” for the prospects of federal
rescheduling.

The D.C. Council extended conditional medical cannabis licenses by 12 months for new operators. Other news includes highlights from the Oct. 8 ABC Board meeting, four unlicensed retailer closures, Maryland’s social equity vendor fair and incubator launch, and Virginia’s 2026 retail cannabis roadmap discussions.

A leading hemp industry organization has sent a letter to President Donald
Trump, applauding him for his role in legalizing the crop during his first
term and imploring him to prevent Congress from “reversing” the reform by
banning hemp products containing any amount of THC.

A Florida appeals court ruled that police cannot search a vehicle based solely on the smell of marijuana, due to the legalization of hemp and medical marijuana in the state. This overturns the "plain smell doctrine" and aligns cannabis searches with other suspected contraband, requiring the odor to be considered as one factor among others. Other states, including Maryland, Minnesota, and Illinois, have also addressed or are addressing similar policies regarding cannabis odor and police searches.

MariMed’s InHouse brand launched its second-annual Help on the Homefront campaign, offering qualifying veterans the chance to win $5,000 to help with housing costs or home improvements. The campaign runs from October 1 to November 30, 2025, with one winner chosen from each of MariMed's four retail markets: Maryland, Massachusetts, Delaware, and Illinois. Veterans aged 21 and over can apply in-store or online, and no purchase is necessary.

D.C. regulators ordered the Temple of Golden Teacher to close due to psilocybin sales, while DC Smoke's license was upheld. ABCA issued fines and made arrests related to unlicensed dispensaries. In Maryland, THC regulation enforcement was restored, and Virginia is launching a safe driving campaign.

The Maryland Cannabis Administration has recalled cannabis products that failed safety compliance testing due to bacterial contamination. Patients and caregivers should check product labels for METRC and production batch numbers.

The provided text summarizes a "Marijuana Moment" newsletter from September 30, 2025. Key points include: the DOJ delaying a marijuana rescheduling challenge, a US citizen freed from Russia over cannabis speaking at a conference, and Ohio marijuana rules changes. It also covers federal, state, local, international, science & health, advocacy, and business news related to cannabis.

*MN’s 1st marijuana event license; KY hemp farmer letter to McConnell;
Study: Anti-rescheduling poll; Snapchat AI blocks cannabis info but OKs
alcohol *

Kentucky hemp farmers are urging Senator Mitch McConnell to abandon his efforts to recriminalize some hemp products, warning of "catastrophic consequences" for their farms and livelihoods. McConnell, who championed the 2018 Farm Bill legalizing hemp, now seeks to ban hemp derivatives with "quantifiable" THC, claiming he never intended to allow intoxicating cannabis products. Farmers argue this would destroy their market and empower the illicit market, advocating instead for responsible regulation like age restrictions and uniform testing. Senator Rand Paul (R-KY) has worked to remove the ban from legislation and is pushing for a bill to triple the legal THC concentration in hemp. The U.S. Hemp Roundtable and an alcohol industry association also oppose the ban, while some GOP lawmakers and a beer industry group express concerns about unregulated hemp products.

D.C. is considering extending conditional licenses to four years due to ABCA crackdowns. Maryland is recalling bacteria-contaminated edibles. Virginia's medical cannabis sales are surging despite patient concerns.

A Republican congressman, James Comer, supports overturning some criminal justice reform policies in Washington D.C., but acknowledges "a trace of racism" in marijuana enforcement. However, he believes advocates have gone too far in expanding these reforms to issues like cashless bail. His committee recently approved a bill to repeal a D.C. law expanding marijuana expungements. Despite his willingness to revisit a rider preventing D.C. from using its own funds for recreational marijuana sales, the House Appropriations Committee has kept the rider intact. Democratic Congresswoman Eleanor Holmes Norton has criticized these actions, arguing they restrict D.C.'s autonomy.

Virginia's new seed-to-sale medical cannabis tracking system, operated by the Virginia Cannabis Control Authority (CCA) and Metrc, has been online for two months, providing real-time data on plants, products, and sales. This system helps the CCA track popular products, plant growth, and sales trends, aiming to protect patients and prevent illegal products. Early data shows nearly half of sales were flower, with concentrates, edibles, and shake trim making up the rest. The CCA plans to create a public dashboard for data transparency. Patients continue to express concerns about high prices and limited access, with some traveling to neighboring states for cheaper products. The system's unveiling coincides with a debate in the General Assembly about legalizing recreational cannabis sales, which lawmakers are considering for as early as 2026. The CCA's current focus remains on refining the medical program and ensuring public safety, with the tracking system allowing regulators to trace products and reduce risks.

The Trump administration is asking a federal court to dismiss a lawsuit
from a Washington, D.C. hemp business challenging the federal government
over a congressional budget restriction that prevents local officials from
establishing and regulating a retail marijuana market.

A Democratic congresswoman is accusing a Republican lawmaker, Rep. Byron Donalds, of hypocrisy for sponsoring legislation to restrict Washington D.C.'s sentencing reform law, despite his own past marijuana and robbery charges being dismissed or expunged. She argues that Donalds was afforded opportunities he is now denying to D.C. youth. The article also details Donalds's mixed record on cannabis policy, including votes against certain marijuana reform efforts despite his personal history, and mentions ongoing congressional interference with D.C.'s cannabis laws, such as the annual appropriations rider preventing recreational marijuana sales.

The Maryland Cannabis Administration has recalled Hi Color Max Chocolate Milk products due to bacterial contamination. This recall of medical cannabis products in Maryland was reported by MJBizDaily.

Senator Rand Paul is concerned about potential legislation that could decimate the hemp industry within the next two weeks, arguing that the cannabis policy movement has become too prohibitionist. He advocates for regulating consumable cannabis products rather than the plant itself, which would ease the burden on farmers and allow for public health precautions without an outright ban. Paul believes that a total ban would create an illegal market and harm livelihoods. He has been working to compromise with other lawmakers and introduced the HEMP Act to increase the legal THC concentration in hemp.

Edible Brands, known for Edible Arrangements, is expanding its cannabis product delivery service, Edibles.com, to 30 states across the U.S., with same-day delivery in several major cities. The company initially tested the service in Texas and has since partnered with cannabis businesses like Wana, Wyld, and Kiva Confections. This expansion comes as states and Congress debate hemp policy, with some proposals aiming to ban hemp products with any amount of THC.

*GOP senator: Congress must “step up” on marijuana; Dem lawmaker talks
Trump & cannabis; OH’s $3B in sales; Study: cannabis as tobacco substitute*

A group of Democratic U.S. Senators are urging congressional leaders to protect hemp legalization in the government spending bill, opposing any language that would harm the American agricultural hemp industry and endanger states' ability to prevent unsafe hemp-derived cannabinoid products from reaching children. They suggest alternatives to a ban, such as restricting sales to adults over 21, standardizing packaging, prohibiting synthetic products, and requiring third-party lab tests. The letter highlights the hemp industry's economic contributions, including 320,000 jobs, $28.4 billion in regulated market activity, and $1.5 billion in state tax revenues.

Maryland's high court has ruled that hemp-derived psychoactive products have always been illegal in the state.

Minnesota dispensaries are now open for adult-use cannabis, with Legacy Cannabis in Duluth being the first state-licensed recreational dispensary. Vireo Growth Inc. is also making its products available, emphasizing community building and responsible access. Previously, adult-use purchases were limited to Native American reservations, but new compacts with tribes are accelerating the market launch.

Sens. Ron Wyden (D-OR) and Jeff Merkley (D-OR) led six other senators on a
letter asking leadership to oppose any move to recriminalize hemp products
with a quantifiable amount of THC, saying it “would deal a fatal blow to
the American farmers who are the foundation of the regulated hemp industry.”

Democratic senators are urging their colleagues to reject a proposed ban on hemp products containing THC, arguing it would destroy the industry. They suggest a regulatory framework instead, including age restrictions, labeling requirements, and testing. This comes after efforts by Sen. Mitch McConnell to recriminalize hemp with quantifiable THC were stripped from a Senate agriculture spending bill. The hemp industry, legalized under the 2018 Farm Bill, supports 320,000 jobs and generates billions in revenue and state tax. Senators Ron Wyden and Jeff Merkley led a letter opposing the ban, while Senator Rand Paul also opposes it and has filed a bill to increase the legal THC concentration in hemp. Concerns have also been raised by the alcohol industry and the U.S. Hemp Roundtable about the lack of clear federal regulations.

Chocolate City Wellness in D.C. has shut down. Maryland reported $18.4M in Q2 cannabis taxes, and delta-8 and delta-10 THC have been ruled illegal in Maryland.

Michigan Senate Democrats are considering a 32 percent wholesale excise tax on marijuana, in addition to the existing 16 percent retail tax, as proposed by Gov. Gretchen Whitmer. This measure aims to fund road repairs and align marijuana taxation with other smoking products. The proposed hike would effectively double the total tax rate on cannabis in Michigan, drawing criticism from advocates who argue it would burden consumers and businesses. Other states have also contemplated or implemented similar tax hikes on marijuana as their markets mature. Michigan recently disbursed nearly $100 million in marijuana tax revenue to cities and tribes, a result of record sales in 2024.

The document is a newsletter from Marijuana Moment, dated September 16, 2025. Key topics include: a push from various groups for federal marijuana legalization, the expected availability of medical marijuana in Kentucky by next month, the Texas Supreme Court declining to hear an appeal on a local marijuana decriminalization law, a New York Assembly Health Committee hearing on psilocybin, and a new op-ed about pending congressional hemp legislation that could ban certain products. The newsletter also covers federal and state cannabis news, local and international updates, science and health studies related to cannabis and psychedelics, and business news in the cannabis industry.